k19- biokima kelainan eritrosit
TRANSCRIPT
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 1/52
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 2/52
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 3/52
Production of Erythrocytes: Erythropoiesis
Figure 17.5
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 4/52
An Erythrocyte (RBC)
Normal Values
RBCs, male 4.7-6.1 x
106/µL
female 4.2-5.4 x
106/µL
Hb, male 13.0-16.0 g/dL
female 12.0-15.0 g/dL
Hct, male 42-53%
female 37-47%
MCH 29±2 pg
MCV 81-94 fL
MCHC 32-37.5%
Practical Values
65% of Fe in Hb
1 g Hb = 3.46 mg Fe
1 mL blood at 15 g/dL Hb = 0.5 mg FeRBC x 3 = Hb
Hb x 3 = Hct
Microcytic < 81 fL
Macrocytic > 94 fL
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 5/52
Erythrocytes (RBCs)
Erythrocytes are anexample of the
complementarity ofstructure and function
Structuralcharacteristics
contribute to its gastransport function
Biconcave shape thathas a huge surface
area relative tovolume
Discounting watercontent, erythrocytes
are more than 97%hemoglobin
ATP is generatedanaerobically, so the
erythrocytes do notconsume the oxygen
they transport
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 6/52
They lackorganelles
no ATP productionin oxidative
phosphorylation
no ability to replacedamaged lipids and
proteins (lowmetabolic activities,
with no ability to
synthesize newproteins or lipids)
Erythrocyte
exceptions
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 7/52
Free radicalsexposure
haemoglobinautoxidation(O2
•- release)
a cellmembrane rich
inpolyunsaturated
fatty acids(susceptible to
lipidperoxidation)
deformation intiny capillaries;catalytic ions
leakage (causeof lipid
peroxidation)
Erythrocyte exceptions
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 8/52
The erythrocyte membrane
50% l ip id bi layer (phosp hol ip id s, cholesterol)
50% pro teins
SDS-PAGE: separation of proteins (band 1-7)
isolation and analysis (10 main proteins)
Integral: Anion exchanger protein, Glycophorin A, B, CPeripheral: Spectrin, Ankyrin, Actin
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 9/52
Red Blood Cell Membrane
Development
Trilaminar, three-dimensional structure
Outermost layer: glycolipids, glycoproteins
Central layer: cholesterol, phospholipids
Inner layer: cytoskeleton
spectrin Composed of alpha & beta chains
Join to form a matrix which strengthens the membraneagainst sheer force and controls biconcave shape
ankrin
membrane proteins
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 10/52
Red Blood Cell Membrane Function
Shape
Provides the optimum surface to volume ratio for respiratory exchange
AND is essential to deformability Provide deformability, elasticity
Allows for passage through microvessels
Provides permeability
Allows water and electrolytes to exchange
RBC controls volume and H2O content primarily through control ofsodium and potassium content
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 11/52
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 12/52
Erythrocyte Membrane Composition
http://www.ruf.rice.edu/~bioslabs/studies/sds-page/rbcmembrane.html
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 13/52
Spectrin: the most prominent component (two isoforms α,β; a tetramer; a meshwork )
fixed to the membrane- ankyrin
binding sites for several other proteins (glycophorin C, actin, band 4.1,
adducin)
This organization keeps the erythrocyte shape.
The erythrocyte membrane
St t f H l bi
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 14/52
Structure of Hemoglobin
Figure 17.4
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 15/52
Hemoglobin Structure Changes
http://www.mfi.ku.dk/PPaulev/chapter8/images/8-3.jpg
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 16/52
http://www.mun.ca/biology/desmid/brian/BIOL3530/DB_Ch09/fig9_24.jpg
Hemoglobin Genes and Gene Products
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 17/52
http://www.blackwellpublishing.com/korfgenetics/figure.asp?chap=13&fig=Fig13-1
http://www.embryology.ch/anglais/qblood/blut03.html
Hemoglobin Genes and Gene Products
HbF: 2 and 2 HbA1: 2 and 2
HbA2: 2 and 2HbE: 2 and 2
Umbilical vesicle
liver
spleen
Bone marrow
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 18/52
Mehta, A. B., and A. V. Hoffbrand. 2000. Haematology at a glance, Blackwell Science, Malden, Mass.
Hemoglobin Gene Product Production
HbF: 2 and 2
HbA1: 2 and 2
HbA2: 2 and 2HbE: 2 and 2
Yolk sac Liver Spleen Bone marrow
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 19/52
The Erythrocytemetabolism
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 20/52
Erythrocyte metabolism
• Glucose as a source of energy
• Glycolysis generates ATP and 2,3-bisphosphoglycerate
• The pentose phosphate pathway produces NADPH
• Glutathione synthesis- the antioxidant defence system
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 21/52
• Energy (ATP) is necessary to keep the erythrocytes in normal functional
state – Shape and deformability (membrane skeleton)
– Membrane transport (Na/K ATP-ase, band 3, …)
– Protection against reactive oxygen species (which oxidate heme iron from Fe 2+ to
Fe3+
, initiate peroxidation of membrane lipids, …
• („anaerobic“) glycolysis – Produces 2,3-BPG as a by-product, which influences Hb-oxygen binding
– The end-product - lactate is released to the bloodstream
– High activity of lactate dehydrogenase in erythrocytes, increased plasmaconcentration as a morker of hemolysis
• 5-10% of glucose diverted to the pentose phosphate pathway, whichproduces NADPH
• Glucose uptake is not insulin-dependent, intracellular glucose metabolism isaffected by insulin
• Erythrocytes do not synthesize glycogene, fatty acids, proteins
Erythrocyte metabolism
Glucose source of energy
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 22/52
Glucose- source of energy
Glucose transporter:
• integral membrane protein (12 membrane-spanning helices)
• a channel for the glucose transport
• insulin-independent transporter
Glycolysis in erythrocytes
1. Source of ATP
• Lactate- the end product
• Cover 90% of energy requirement
2. Generate 2,3-bisphosphoglycerate (2,3-BPG)
• a major reaction pathway for the consumption of glucose in erythrocytes
• the specific binding of 2,3-BPG to deoxyhemoglobin decreases the oxygen affinity
of hemoglobin and facilites oxygen release in tissues
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 23/52
Red Blood Cell Metabolism Metabolism
These pathways are essential for oxygen transport and maintainingthe physical characteristics of the RBC.
Embden-Meyerhof glycolytic pathway Generates 90% of energy needed by RBC’s
Glucose is metabolized and generates two molecules of ATP (energy).
Hexose monophosphate shunt Metabolizes 5-10% of glucose.
NADPH is end product
Protects the RBC from oxidative injury.
Most common defect is deficiency of the enzyme glucose-6-phosphatedehydrogenase (G-6PD).
If the pathway is deficient, intracellular oxidants can’t be neutralized andglobin denatures then precipitates. The precipitates are referred to as Heinz bodies. (Must use supravital stain to visualize them.)
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 24/52
Red Blood Cell Metabolism Methemoglobin reductase pathway
Maintains iron in the ferrous (Fe2) state.
In the absence of the enzyme (methemoglobin reductase),
methemoglobin accumulates and it cannot carry oxygen. Leubering-Rapaport shunt
Allows the RBC to regulate oxygen transport during conditions ofhypoxia or acid-base imbalance.
Permits the accumulation of 2,3-DPG which is essential formaintaining normal oxygen tension, regulating hemoglobin affinity
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 25/52
E r
y t h r o c y t e
m e t a b o l i s m
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 26/52
Anaerobic glycolysis and 2,3-BPG
• In erythrocytes, one of the glycolytic
reactions (which produces ATP) can bebypassed
– 2,3-bisfosfoglycerate is produced as anintermediary product
– energy is dissipated as heat
• This shunt enables glycolysis to run evenwhen energy requirements are low
2 3 bisphosphoglycerate
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 27/52
2,3-bisphosphoglycerate
• Allosteric effector of haemoglobin:
– binds to deoxyhaemoglobin (a central cavity capable of binding 2,3-BPG)
– decreases haemoglobin‘s O2 affinity
• Clinical aspects:
– In people with high-altitude adaptation or smokers the concentration of 2,3-BPG
in the blood is increased (low oxygen supply)
– Fetal haemoglobin has low BPG affinity - the higher O2 affinity - facilitates the
transfer of O2 to the fetus via the placenta
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 28/52
2,3-BPG and hemoglobin-oxygen binding
• DeoxyHb affinity to bind 2,3-BPG is 100-foldhigher that that of OxyHb
• Binding of 2,3-BPG to Hb decreases Hbaffinity to bind O2 → right shift of the curve
2 mmol/l
4 mmol/l
6 mmol/l
H b s a t u r a
t i o n
pO2
t i s s u e s
l u n g s
Lungs
Only a small decreaseof oxygen loading
Tissues
Significant increase
of oxygen
unloading
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 29/52
Depends on pH ([H+]), CO2, BPG (DPG), Temp
Factors Affecting Binding of O2
pH_
BPG or T; right shift
pH
BPG or T_; left shift
The pentose phosphate pathway in erythrocytes
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 30/52
The pentose phosphate pathway in erythrocytes
• Generates NADPH - reduction of glutathione (eliminates H2O2 formed in erythrocytes)
Clinical aspect:
• Glucose-6-phosphate dehydrogenase deficiency
– Causes hemolytic anemia (decreased production of NADPH - reduced protection
against oxidative stress - haemoglobin oxidation and Heinz bodies formation,
membrane lipid peroxidation and hemolysis) – Hemolytic crises are evocated by drugs (primaquine, sulphonamide antibiotics)
and foods (broad beans)
– The most common enzyme deficiency disease in the world (100 million people)
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 31/52
Pentose phosphate pathway
• Alternative pathway of glucose metabolism
• In several cycles, it leads to complete glucose oxidation
– Oxidation accomplished through dehydrogenation (without O2) – Produces CO2 (not produced by glycolysis)
– Does not produce ATP (glycolysis produces ATP)
– The acceptor of H+ is NADP (it is NAD in glycolysis)
• NADPH provides H+ for reduction of oxidated glutathione
contribuing to protection against reactive oxygen species
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 32/52
OxyhaemoglobinO
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 33/52
Haemoglobin
Methaemoglobin
Methaemoglobin reductase
O2
Superoxide
Superoxide dismutase
H2O2
Catalase
½ O2+H2O
Glutathione peroxidase
H2O
GSH
GSSG
Glutathione reductase
NADPH
NADP+
Pentose phosphate
pathway
GSH-reduced form; GSSG-oxidized form of glutathione
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 34/52
Hb oxygen saturation and erythrocyte metabolism
• Phosphofructokinase (PFK) binds to
band 3 (B3P)
• Preferention of pentose phospate
pathway → higher production of NADPH
→higher antioxidant capacity
• DeoxHb beats the competition of
PFK in binding to B3P
• Preferention of glycolysis, more 2,3-
BPG is produced → oxygen binding
curve shifts to the right, more oxygen
released
High oxygen saturation Low oxygen saturation
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 35/52
ROS = molecules, atoms or ions capable to react avidly with lipids (membranes),proteins, nucleic acids and impair their structure and function
Radicals: ROS with an unpaired electron
Increased ROS production and/or decreased degradation = oxidative stress
Important reactions- Superoxide generation: O2 + e- → O2
•-
- Fenton reaction: Fe2+ + H2 O2 → Fe3+ + OH + OH•-
- Haber-Weiss reaction: O2•- + H2O2 → OH + OH•-
- Superoxiddismutase (SOD): O2•- + O2
•- → H2O2 + O2
- Catalase (CAT): 2 H2O2 → 2 H2O + O2
- Glutathionperoxidase (GPX): 2 GSH + R-O-OH → GSSG + H2O + ROH
2 GSH + H2O2 → GSSG + 2 H2O
Reactive oxygen species
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 36/52
ROS in the erythrocytes
• High O2 content
• A transition metal: Fe (2+→3+), contained in Hb
• Hb autooxidation:
HemFe2+ + O2 ↔ (Hem Fe2+~O2 ↔ HemFe3+~ O2•-) ↔ HemFe3+ + ↔ O2
•-
• Regeneration of Hb: methemoglobinreductase
• Erythrocytes are rich in antioxidant enzymes SOD, GPX, CAT
• Key role of glutathione (γ-glutamyl-cysteinyl-glycin, GSH)
– Reaction of GPX
– Direct reaction with molecules modified by ROS
• GSH regeneration by glutathionreductase
GSSG + NADPH + H+ → 2 GSH + NADP+
• Pentose phosphate pathway is the source of NADPH + H+:
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 37/52
NADPH and antioxidant protection
• NADPH + H+ is produced in a reaction catalyzed by glucose-6-
phosphatedehydrogenase (G6PD)
• G6PD deficiency
– Probably the most frequent enzymopathy (~100 million people, 300 geneticvariants of the enzyme)
– Frequent in mediterranean countries, tropical Africa, Asia
– Results in hemolytic anemia, worsened by some foods (broad beans) or drugswhich act as oxidants
– Hemolysis is caused by oxidative impairment of membrane lipids (peroxidation),proteins (oxidation of thiol groups to disulfides)
M h l bi i
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 38/52
Methemoglobinemia
• About 3% of Hb is converted to metHb and back in 24 hours, butmetHb concentration is normally very low
• Causes of increased metHb concentration
– Inherited deficiency of methemoglobinreductase – Increased susceptibility of abnormal Hb variants to autooxidation (HbM,
HbS - sickle)
– toxic chemicals: aniline, sulfonamides, nitrites (conservants in food,produced by microbial reduction of nitrates contained in fruits andvegetables)
• MetHb cannot bind oxygen – hypoxia
• Cyanosis: bluish colour of skin due to presence of metHb – becomes apparent at metHb levels above 15g metHb/l (about 50g/l
deoxyHb is required to produce cynosis)
I h it d ethemoglobinemia
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 39/52
The blue people of Troublesome Creek. Science 1982. Ilustrace Walt Spitzmiller.
Inherited methemoglobinemia
Glutathione synthesis in erythrocytes
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 40/52
GlutathioneEli i ti f H O d i h d id
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 41/52
Elimination of H2O2 and organic hydroperoxides
1. Cofactor for the glutathione peroxidase (removes H2O2 formed in
erythrocytes)
2. Involved in ascorbic acid metabolism
3. Prevents protein –SH groups from oxidizing and cross-linking
Gly
Cys
Glu
Gly
Cys
Glu
Gly
Cys SH
Glu
S S
Oxidized form of glutathione
(dimer, disulphide)
Reduced form of glutathione
(monomer)
Glutathione peroxidase
Glutathione reductase
+ R-O-O-H
+ H2O
+ NADPH
Haemoglobin autoxidation• 3% of the haemoglobin undergoes oxidation every day
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 42/52
• a constant flux of O2•-
Hem - Fe2+- O2 Hem - Fe3+ - O2•-
Methaemoglobin reductase• Converts methaemoglobin back to ferrous haemoglobin to permit continued O2
transport
• System containing FAD, cytochrome b5 and NADH (glycolysis)
Methaemoglobinemia1. Congeni tal type
– methaemoglobin reductase deficiency (AR)
– variant haemoglobin M (HbM)- mutation; tend to be oxidized tomethaemoglobin
2. Ac quired type - drugs or chemicals (sulphonamides, aniline)
Visual indicator- a blue tint to the skin (10% of metHb)Treated- reductants (methylene blue, ascorbic acid)
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 43/52
2. Glutathione peroxidase
H O b li it d ti t H O ith id ti f d d
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 44/52
• removes H2O2 by coupling its reduction to H2O with oxidation of reducedglutathione (GSH)
H2O2+2GSH GSSG+2H2O
Glutathione reductase
• reduces oxidized glutathione back to reduced
GSSG+NADPH+H+ 2GSH+NADP+
• NADPH- the pentose phosphate pathway (glucose-6-phosphate dehydrogenase)
Cooperation of glutathione peroxidase and catalase
• The concentration of H2O2 is raised- catalase becomes more important (high Km
for H2O2)
Low-molecular mass antioxidants
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 45/52
α-tocopherol (vitamin E)
• Present in the erythrocyte membrane
• Prevents lipid peroxidation (chain-breaking antioxidant)
α-TocH+LO2• α-Toc•+LO2H
Ascorbic acid (vitamin C)
• Present in the cytoplasm• Recycles α-tocopherol
• Dehydroascorbate reductase (GSH-dependent) regeneratesascorbate
Haemoglobinopathy• abnormal structure of the haemoglobin (mutation)
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 46/52
abnormal structure of the haemoglobin (mutation)
• large number of haemoglobin mutations, a fraction has deleterious effects
• sickling, change in O2 affinity, heme loss or dissociation of tetramer
• haemoglobin M and S, and thalassemias
Haemoglobin M
• replacement of the histidine (E8 or F7) in α or β-chain by the tyrosine
• the iron in the heme group is in the Fe3+ state (methaemoglobin) stabilized
by the tyrosine
• methaemoglobin can not bind oxygen
Thalassemias
• genetic defects- α or β-chains are not produced (α or β-thalassemia)
Sickle Cell Disease
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 47/52
http://www.emedicine.com/ped/TOPIC2096.HTM
Rare combinations of HbS with HbD Los Angeles, HbO Arab, G-Philadelphia, among others
Sickle Cell Disease
(>6 major genotypes)at least 1 sickle gene, hemoglobin S (HbS) ≥ 50% Hb present.
homozygotic HbSS (sickle cell anemia) - HbS = 100% Hb present
HbS beta-0 thalassemia - Severe double heterozygote for HbS and beta-0 thalassemia; almost
indistinguishable from sickle cell anemia phenotypically (MCV low)
HbSC disease - Double heterozygote for HbS and HbC, with intermediate clinical severity
HbS/hereditary persistence of fetal hemoglobin (S/HPHP) - Mild form or symptom free
HbS/HbE syndrome - Rare and generally mild clinical course
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 48/52
Haemoglobin S (sickle-cell)
• Causes a sickle cell anemia
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 49/52
• Causes a sickle-cell anemia
• Erythrocytes adopt an elongated sickle shape due to the
aggregation of the haemoglobin S
Glycosylated haemoglobin (HbA1C)
• formed by hemoglobin's exposure to high plasma levels of glucose
ti l l ti ( l ti ) b di t t i
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 50/52
• non-enzymatic glycolysation (glycation)- sugar bonding to a protein
• normal level HbA1- 5%; a buildup of HbA1- increased glucose concentration
• the HbA1 level is proportional to average blood glucose concentration over previousweeks; in individuals with poorly controlled diabetes, increases in the quantities ofthese glycated hemoglobins are noted (patients monitoring)
Sugar CHO + NH2 CH2 Protein
Sugar CH N CH2 Protein
Sugar CH2 NH CH2 Protein
Schiff base
Glycosylated protein
Amadori reaction
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 51/52
Checkpoint Which erythrocyte metabolic pathway is
responsible for providing the majority ofcellular energy?
For regulating oxygen affinity?
For maintaining hemoglobin in a reducedstate?
Summary
Erythrocytes lack cell organelles; their membranes are rich in
polyunsaturated fatty acids and proteins (fluidity and elasticity)
8/12/2019 K19- Biokima Kelainan Eritrosit
http://slidepdf.com/reader/full/k19-biokima-kelainan-eritrosit 52/52
polyunsaturated fatty acids and proteins (fluidity and elasticity)
Glucose as a energy source
Glycolysis generates ATP and 2,3-BPG; the pentose phosphate pathway
produces NADPH
Haemoglobin autoxidation forms free radicals
Free radicals are removed by the antioxidant defence system with glutathione
and NADPH
There is a large number of haemoglobin mutations; some of them are
pathological (haemoglobinopathy)